The effect of hexetidine mouthwash on the prevention of plaque and gingival inflammation: A systematic review

International Journal of Dental Hygiene

Volumn 9, Issue 3, 2011, Pages 182-190

  Afennich, F ^a   Slot, D E ^b   Hossainian, N ^c   Van Der Weijden, G A ^b,c  

^a UNIVERSITY OF APPLIED SCIENCES UTRECHT   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c Clinic for Periodontology in Utrecht   (Netherlands)

Author keywords

Bleeding; Gingivitis; Hexetidine; Hexetidine mouthwash; Plaque; Systematic review

Indexed keywords

CHLORHEXIDINE; HEXETIDINE; MOUTHWASH; TOPICAL ANTIINFECTIVE AGENT;

GINGIVA BLEEDING; GINGIVITIS; HUMAN; METHODOLOGY; MOUTH HYGIENE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; TOOTH PLAQUE;

ANTI-INFECTIVE AGENTS, LOCAL; CHLORHEXIDINE; DENTAL PLAQUE; GINGIVAL HEMORRHAGE; GINGIVITIS; HEXETIDINE; HUMANS; MOUTHWASHES; ORAL HYGIENE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN;

EID: 84855749411     PISSN: 16015029     EISSN: 16015037     Source Type: Journal    
DOI: 10.1111/j.1601-5037.2010.00478.x     Document Type: Review

References (45)

1. Keyes PH, Jordan HV. Periodontal lesions in the Syrian hamster-III Findings related to an infectious and transmissible component. Arch Oral Biol 1964; 32: 377-400.
2. Löe H, Theilade E, Jensen SB. Experimental gingivitis in man. J Periodontol 1965; 36: 177-187.
3. Lindhe J, Hamp SE, Löe H. Experimental periodontitis in the Beagle dog. J Periodont Res 1973; 8: 1-10.
4. Axelsson P, Nyström B, Lindhe J. The long-term effect of a plaque control program on tooth mortality, caries and periodontal disease in adults. Results after 30years of maintenance. J Clin Periodontol 2004; 31: 749-757.
5. Paraskevas S. Randomized controlled clinical trials on agents used for chemical plaque control. Int J Dent Hyg 2005; 3: 162-178.
6. Eley BM. Antibacterial agents in the control of supragingival plaque - a review. Br Dent J 1999; 186: 286-296.
7. Roberts WR, Addy M. Comparison of the in vivo and in vitro antibacterial properties of antiseptic mouthrinses containing chlorhexidine, alexidine, cetylpyridinium chloride and hexetidine. J Clin Periodontol 1981; 8: 295-310.
8. Ashley KC. The antimicrobial properties of two commonly used antiseptic mouthwashes-Corsodyl and Oraldene. J Appl Bacteriol 1984; 56: 221-225.
9. Wile DB, Dinsdale JR, Joynson DH. Hexetidine (Oraldene): a case report on its antibacterial and antifungal properties on the oral flora in healthy subjects. Curr Med Res Opin 1986; 10: 82-88.
10. Mörmann JE, Muhlemann HR. Synergistic inhibitory effect of zinc and hexetidine on in vitro growth and acid production of Streptococcus mutans. J Dent Res 1983; 62: 135-137.
11. Kolokotronis A, Sofianou D, Doumboias I, Papanagiotou P. Comparison in vivo and in vitro of the antibacterial action of the antiseptics hexetidine and povidone-iodine. ZWR 1983; 92: 44-46.
12. Anonymous. Hexetidine. J Am Med Assoc 1957; 165: 1142-1143.
13. Anonymous. Oraldene - an antiseptic mouthwash. Drug Ther Bull 1970; 8: 87-88.
14. Dutch Cochrane Center. RCT-checklist of the Dutch Cochrane Center. Available at: http://www.cochrane.nl/Files/documents/Checklists/RCT.pdf (accessed 12 October 2008).
15. CONSORT. Consort statement. Available at: http://www.consortstatement.org/mod_product/uploads/CONSORT%202001%20checklist.doc (accessed 12 May 2009).
16. Moher D, Schulz KF, Altman D. CONSORT Group (Consolidated Standards of Reporting Trials). The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA 2001; 285: 1987-1991.
17. Moher D, Schulz KF, Altman DG. CONSORT GROUP (Consolidated Standards of Reporting Trials). The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. Ann Intern Med 2001; 134: 657-662.
18. Moher D, Schulz KF, Altman DG. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 2001; 357: 1191-1194.
19. Moher D, Schulz KF, Altman DG; CONSORT. The CONSORT statement: revised recommendations for improving the quality of reports of parallel group randomized trials. BMC Med Res Methodol 2001; 1: 2.
20. Esposito M, Coulthard P, Worthington HV, Jokstad A. Quality assessment of randomized controlled trials of oral implants. Int J Oral Maxillofac Implants 2001; 16: 783-792.
21. Needleman I, Moles DR, Worthington H. Evidence-based periodontology, systematic reviews and research quality. Periodontol 2000 2005; 37: 12-28.
22. Verhagen AP, de Vet HC, de Bie RA et al. The Delphi list: a criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus. J Clin Epidemiol 1998; 51: 1235-1241.
23. Centre for Evidence-based Medicine, University of Oxford (England). Levels of Evidence (March 2009). Available at: http://www.cebm.net/index.aspx?o=1025 (accessed 11 August 2010).
24. American Dental Association. Acceptance Program Guidelines. Chemotherapeutic Products for Control of Gingivitis (July 2008). Available at: http://www.ada.org/ada/seal/standards/guide_chemo_ging.pdf (accessed 11 August 2010).
25. Cowell CR, Saxton CA, Sheiham A, Wagg BJ. Testing therapeutic measures for controlling chronic gingivitis in man: a suggested protocol. J Clin Periodontol 1975; 2: 231-240.
26. American Dental Association. Acceptance Program Guidelines. Adjunctive Dental Therapies for the Reduction of Plaque and Gingivitis (September 1997). Available at: http://www.ada.org/ada/seal/standards/guide_adjunctive.pdf (accessed 11 August 2010).
27. Virga C, Beltramo D, Landa C, Passalacqua N, Dorronsoro S. A comparative study in vivo of the therapeutic effect of triclosan, hexetidine and chitosan. Acta Odontol Latinoam 2002; 15: 3-9.
28. Grytten J, Tollefsen T, Afseth J. The effect of a combination of copper and hexetidine on plaque formation and the amount of copper retained by dental plaque bacteria. Acta Odontol Scand 1987; 45: 429-433.
29. Hefti AF, Huber B. The effect on early plaque formation, gingivitis and salivary bacterial counts of mouthwashes containing hexetidine/zinc, aminefluoride/tin or chlorhexidine. J Clin Periodontol 1987; 14: 515-518.
30. Giertsen E, Svatun B, Saxton A. Plaque inhibition by hexetidine and zinc. Scand J Dent Res 1987; 95: 49-54.
31. Bergenholtz A, Hänström L. The plaque-inhibiting effect of hexetidine (Oraldene)-mouthwash compared to that of chlorhexidine. Community Dent Oral Epidemiol 1974; 2: 70-74.
32. Harper PR, Milsom S, Wade W, Addy M, Moran J, Newcombe RG. An approach to efficacy screening of mouthrinses: studies on a group of French products (II). Inhibition of salivary bacteria and plaque in vivo. J Clin Periodontol 1995; 22: 723-727.
33. Sharma NC, Galustians HJ, Qaqish J, Charles CH, Vincent JW, McGuire JA. Antiplaque and antigingivitis effectiveness of a hexetidine mouthwash. J Clin Periodontol 2003; 30: 590-594.
34. Williams MJ, Adams D, Hillam DG, Ashley KC. The effect of hexetidine 0.1% in the control of dental plaque. Br Dent J 1987; 163: 300-302.
35. Chadwick B, Addy M, Walker DM. Hexetidine mouthrinse in the management of minor aphthous ulceration and as an adjunct to oral hygiene. Br Dent J 1991; 171: 83-87.
36. Ernst CP, Canbek K, Dillenburger A, Willershausen B. Clinical study on the effectiveness and side effects of hexetidine and chlorhexidine mouthrinses versus a negative control. Quintessence Int 2005; 36: 641-652.
37. Needleman IG. Guide to systematic reviews. J Clin Periodontol 2002; 29: 6-9.
38. Löe H, Schiott CR. The effect of mouthrinses and topical application of chlorhexidine on the development of dental plaque and gingivitis in man. J Periodont Res 1970; 5: 79-83.
39. Gjermo P, Baastad KL, Rölla G. The plaque inhibiting capacity of 11 antibacterial compounds. J Periodontal Res 1970; 5: 102-109.
40. Pontefract H, Hughes J, Kemp K, Yates R, Newcombe RG, Addy M. The erosive effects of some mouthrinses on enamel. A study in situ. J Clin Periodontol 2001; 28: 319-324.
41. Silness J, Löe H. Periodontal disease in pregnancy. II. Correlation between oral hygiene and periodontal condition. Acta Odontol Scand 1964; 22: 121-135.
42. Turesky S, Gilmore ND, Glickman I. Reduced plaque formation by the chloromethyl analogue of Vitamine C. J Periodontol 1970; 41: 41-43.
43. Lange DE, Plagmann HC, Eenboom A, Promesberger A. klinische Bewertungsverfahren zur Objektivierung der Mundhygiene. Dtsch Zahnärztl Z 1977; 32: 44-48.
44. Van der Weijden GA, Timmerman MF, Nijboer A, Reijerse E, Van der Velden U. Comparison of different approaches to assess bleeding on probing as indicators of gingivitis. J Clin Periodontol 1994; 21: 589-594.
45. Löe H. The gingival index, the plaque index and the retention index systems. J Periodontol 1967; 38: 610-616.